A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
// Xin Zhou 1, * , Wei Wen 2, * , Xia Shan 3, * , Wei Zhu 1 , Jing Xu 1 , Renhua Guo 1 , Wenfang Cheng 4 , Fang Wang 5 , Lian-Wen Qi 6 , Yan Chen 7 , Zebo Huang 1 , Tongshan Wang 1 , Danxia Zhu 8 , Ping Liu 1, 9 , Yongqian Shu 1, 9 1 Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China 2 Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China 3 Department of Respiration, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 210000, PR China 4 Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China 5 Department of Cardiology, First Affiliated Hospital of Nanjing Medical University,Nanjing 210029, PR China 6 State Key Laboratory of Natural Medicines and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, 210009, China 7 Department of Emergency, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China 8 Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China 9 Cancer Center of Nanjing Medical University, Nanjing 210029, China * These authors contributed equally to this work Correspondence to: Wei Zhu, email: zhuwei@njmu.edu.cn Ping Liu, email: liupinga28@163.com Yongqian Shu, email: shuyongqian@njmu.edu.cn Keywords: plasma, miRNA, lung adenocarcinoma, diagnosis, exosomes Received: July 25, 2016 Accepted: December 13, 2016 Published: December 27, 2016 ABSTRACT Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA) patients might serve as biomarkers for LA detection. MiRNA expression profiling was performed using Exiqon panels followed by the verification (30 LA VS. 10 healthy controls (HCs)) with quantitative reverse transcription polymerase chain reaction (qRT-PCR) in the screening phase. Identified miRNAs were confirmed through training (42 LA VS. 32 HCs) and testing stages (66 LA VS. 62 HCs) by using qRT-PCR based absolute quantification methods. A total of six up-regulated plasma miRNAs (miR-19b-3p, miR-21-5p, miR-221-3p, miR-409-3p, miR-425-5p and miR-584-5p) were identified. The six-miRNA panel could discriminate LA patients from HCs with areas under the receiver operating characteristic curve of 0.72, 0.74 and 0.84 for the training, testing and the external validation stage (33 LA VS. 30 HCs), respectively. All the miRNAs identified except miR-584-5p were significantly up-regulated in LA tissues. MiR-19-3p, miR-21-5p, miR-409-3p and miR-425-5p showed high expression in arterial plasma with borderline significance. Additionally, miR-19-3p, miR-21-5p and miR-221-3p were significantly up-regulated in exosomes extracted from LA peripheral plasma samples. In conclusion, we identified a six-miRNA panel in peripheral plasma which might give assistance to the detection of LA at least for Asian population to a certain extent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · cited 1×
“But potential overdiagnosis and harmful effects induced by radiation limit their use in the clinical [8].”
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Cited by
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0492-1 · Cited by 527
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., & Syed, M. A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.003 · Cited by 449
Metadata
- Authors
- Zhou, X., Wen, W., Shan, X., Zhu, W., Xu, J., Guo, R., Cheng, W., Wang, F., Qi, L.-W., Chen, Y., Huang, Z., Wang, T., Zhu, D., Liu, P., & Shu, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-12-27
- Volume
- 8
- Issue
- 4
- Pages
- 6513-6525
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2560911552
- Cited by
- 166
- References
- 3
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.